Healthcare Quality and Worker Safety Information
Briggs Healthcare
JANUARY 11, 2024
Nirsevimab (Beyfortus, Sanofi and AstraZeneca) is a long-acting monoclonal antibody immunization recommended for preventing RSV-associated lower respiratory tract disease in young children. Infants and children recommended to receive nirsevimab should be immunized as quickly as possible.
Let's personalize your content